evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract
18070,GENE_SUMMARY,,"EPHA3 encodes a receptor tyrosine kinase that is involved in numerous developmental processes, particularly in the nervous system. Overexpression of EPHA3 is found in glioblastoma, among other cancers.",,2017-04-10,,2042,EPHA3,EPH receptor A3,False,ENST00000336596,NM_005233.5,ETK1,HEK4,TYRO4,ETK,EK4,HEK,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18071,GENE_BACKGROUND,,"EPHA3 (ephrin receptor A3) is a receptor tyrosine kinase that preferentially binds glycosylphosphatidylinositol (GPI)-anchored ephrins resulting in activation of downstream signaling pathways that control cell adhesion, cell migration, cells spreading and proliferation (PMID: 11870224). EPHA3 is highly expressed during embryonic development (PMID: 10197531, 9883737, 25391995) and is overexpressed in various cancer types, including sarcoma, leukemia, glioblastoma and hepatocellular cancer (PMID: 25391995, 23410976, 28415715, 2792259 ). EPHA3 loss-of-function mutations have been identified in various cancer types including lung cancer, melanoma and non-melanoma skin cancers resulting in decreased EPHA3 signaling and enhanced cellular proliferation (cBioPortal, MSKCC, Sept. 2017) (PMID: 22829656, 22242939). EPHA3-targeted antibodies have been tested in preclinical studies and demonstrate anti-tumor effects in mouse models (PMID: 25125683, 16061656).",,2017-09-12,,2042,EPHA3,EPH receptor A3,False,ENST00000336596,NM_005233.5,ETK1,HEK4,TYRO4,ETK,EK4,HEK,False,22829656,Effects of cancer-associated EPHA3 mutations on lung cancer.,Journal of the National Cancer Institute,2018-08-08T20:12:00,104,15,1182-97,Zhuang G et al,doi: 10.1093/jnci/djs297,,0001-08-08,,28415715,Epha3 acts as proangiogenic factor in multiple myeloma.,Oncotarget,2018-05-23T20:17:00,8,21,34298-34309,Caivano A et al,doi: 10.18632/oncotarget.16100,,2018-05-23T03:43:09,,2792259,The role of subicular outputs in the development of the partial reinforcement extinction effect.,Experimental brain research,1989,77,True,153-60,Rawlins JN et al,,,Rawlins JN et al. Experimental brain research. 1989;77(1)153-60.,,25391995,EphA3 biology and cancer.,"Growth factors (Chur, Switzerland)",2017-12-01T20:14:00,32,6,176-89,Janes PW et al,doi: 10.3109/08977194.2014.982276,,0001-12-01,,16061656,Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents.,Cancer research,2018-08-01T20:05:00,65,15,6745-54,Vearing C et al,,,0001-08-01,,23410976,EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.,Cancer cell,2018-02-11T20:13:00,23,2,238-48,Day BW et al,doi: 10.1016/j.ccr.2013.01.007,,0001-02-11,,10197531,EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains.,Neuron,0001-03-01,22,3,511-24,Br√ºckner K et al,,,0001-03-01,,9883737,"PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands.",Neuron,0001-12-01,21,6,1453-63,Torres R et al,,,0001-12-01,,22242939,Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.,Biochemistry,2018-02-21T20:12:00,51,7,1464-75,Lisabeth EM et al,doi: 10.1021/bi2014079,,0001-02-21,,25125683,Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.,Cancer research,2018-08-15T20:14:00,74,16,4470-81,Vail ME et al,doi: 10.1158/0008-5472.CAN-14-0218,,0001-08-15,,11870224,"Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.",Journal of cell science,2018-03-01T20:02:00,115,Pt 5,1059-72,Lawrenson ID et al,,,0001-03-01,
